Literature DB >> 31585502

Gold Nanobipyramids as Second Near Infrared Optical Coherence Tomography Contrast Agents for in Vivo Multiplexing Studies.

Peng Si1,2, Saba Shevidi1,2, Edwin Yuan1,2, Ke Yuan3, Ziv Lautman1,2, Stefanie S Jeffrey4, George W Sledge3, Adam de la Zerda1,2,5,6.   

Abstract

Developing contrast-enhanced optical coherence tomography (OCT) techniques is important for specific imaging of tissue lesions, molecular imaging, cell-tracking, and highly sensitive microangiography and lymphangiography. Multiplexed OCT imaging in the second near-infrared (NIR-II) window is highly desirable since it allows simultaneous imaging and tracking of multiple biological events in high resolution with deeper tissue penetration in vivo. Here we demonstrate that gold nanobipyramids can function as OCT multiplexing contrast agents, allowing high-resolution imaging of two separate lymphatic flows occurring simultaneously from different drainage basins into the same lymph node in a live mouse. Contrast-enhanced multiplexed lymphangiography of a melanoma tumor in vivo shows that the peritumoral lymph flow upstream of the tumor is unidirectional, and tumor is accessible to such flow. Whereas the lymphatic drainage coming out from the tumor is multidirectional. We also demonstrate real-time tracking of the contrast agents draining from a melanoma tumor specifically to the sentinel lymph node of the tumor and the three-dimensional distribution of the contrast agents in the lymph node.

Entities:  

Keywords:  Gold nanoparticle; contrast agent; in vivo imaging; multiplexing; optical coherence tomography; tumor lymphatic system

Mesh:

Substances:

Year:  2019        PMID: 31585502     DOI: 10.1021/acs.nanolett.9b03344

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  8 in total

1.  Methylene blue-filled biodegradable polymer particles as a contrast agent for optical coherence tomography.

Authors:  Jorge A Palma-Chavez; Wihan Kim; Michael Serafino; Javier A Jo; Phapanin Charoenphol; Brian E Applegate
Journal:  Biomed Opt Express       Date:  2020-07-10       Impact factor: 3.562

Review 2.  Gold nanoparticles to enhance ophthalmic imaging.

Authors:  Fang Chen; Peng Si; Adam de la Zerda; Jesse V Jokerst; David Myung
Journal:  Biomater Sci       Date:  2020-10-15       Impact factor: 6.843

3.  Spectral- and Polarization-Dependent Scattering of Gold Nanobipyramids for Exogenous Contrast in Optical Coherence Tomography.

Authors:  Pelham Keahey; Peng Si; Mohammad Razavi; Shangjie Yu; Norman Lippok; Martin Villiger; Timothy P Padera; Adam de la Zerda; Brett Bouma
Journal:  Nano Lett       Date:  2021-10-13       Impact factor: 12.262

4.  Mesoporous Silica-Coated Gold Nanoparticles for Multimodal Imaging and Reactive Oxygen Species Sensing of Stem Cells.

Authors:  Chloe Trayford; Darragh Crosbie; Timo Rademakers; Clemens van Blitterswijk; Rudy Nuijts; Stefano Ferrari; Pamela Habibovic; Vanessa LaPointe; Mor Dickman; Sabine van Rijt
Journal:  ACS Appl Nano Mater       Date:  2022-03-14

Review 5.  Gold nanomaterials for optical biosensing and bioimaging.

Authors:  Peng Si; Nasrin Razmi; Omer Nur; Shipra Solanki; Chandra Mouli Pandey; Rajinder K Gupta; Bansi D Malhotra; Magnus Willander; Adam de la Zerda
Journal:  Nanoscale Adv       Date:  2021-04-14

6.  Mie theory and the dichroic effect for spherical gold nanoparticles: an experimental approach.

Authors:  Emma G Wrigglesworth; James H Johnston
Journal:  Nanoscale Adv       Date:  2021-05-13

Review 7.  Research progress on the application of optical coherence tomography in the field of oncology.

Authors:  Linhai Yang; Yulun Chen; Shuting Ling; Jing Wang; Guangxing Wang; Bei Zhang; Hengyu Zhao; Qingliang Zhao; Jingsong Mao
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

Review 8.  Molecular Contrast Optical Coherence Tomography and Its Applications in Medicine.

Authors:  Ancong Wang; Wenliu Qi; Tianxin Gao; Xiaoying Tang
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.